Optimizing maintenance of fully implanted venous catheters for cancer patients
Official title: Maintenance Optimization of the Fully Implanted Venous Catheter
Run by Clinical Academic Center (2CA-Braga) · NCT05411666 · Data updated 2026-11-12
This study is testing whether regularly cleaning implanted catheters with saline helps cancer patients more than not cleaning them at all.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 176 (estimated) |
| Sponsor | Clinical Academic Center (2CA-Braga) Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Braga) |
| Status | Recruiting |
| Started | June 30, 2020 |
| Main results expected | June 2026 |
| Study ends | July 2026 |
| Registry record updated | August 15, 2025 |
| Trial ID | NCT05411666 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are cancer patients over 18 years old who have undergone placement of a fully implanted central venous catheter for chemotherapy within the last 10 weeks.
✕Probably not a fit
Patients with metastases, those on anticoagulant medication, or individuals with a history of CVCTI-related adverse events may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the necessity and frequency of maintenance for fully implanted central venous catheters (CVCTI) used in cancer patients. It compares two approaches: maintaining the catheter with saline solution versus no maintenance at all. The goal is to clarify existing discrepancies in maintenance practices across different cancer centers and to establish a standardized approach. By assessing the outcomes of these two methods, the study aims to improve patient care and catheter management.
Why it matters
Potential benefit: If successful, this study could lead to more effective and standardized maintenance practices for central venous catheters, enhancing patient comfort and reducing complications.
How similar studies have gone: While there is ongoing debate regarding catheter maintenance practices, this specific approach has not been extensively tested in prior studies, making it a novel investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 18 years of age. * Cancer patients, undergoing placement of CVCTI for chemotherapy, in follow-up, who finished chemotherapy up to a maximum period of 10 weeks. * Eastern Cooperative Oncology Group (ECOG) status of 0 or 1 * Evidence of signed and dated informed consent indicating that the patient has been informed of all relevant aspects of the study and agrees to participate. Exclusion Criteria: * Presence of metastases or any other condition that may be an indication for intravenous treatments or additional chemotherapy regimens * History of CVCTI-related adverse events during the treatment phase * Patients on anticoagulant medication * History of thrombophilia * Pregnancy/Breastfeeding
Where it's running
-
Serviço de Hospital de Dia, Hospital de Braga
Braga, Portugal Recruiting
Study contacts
- Principal investigator: Ema Alves — Serviço de Hospital de Dia, Hospital de Braga, EPE
- Study coordinator: Rosana Magalhaes
- Email: cro@ccabraga.org
- Phone: +351 253 027 249
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Pramipexole to Treat Resistant Obsessive-Compulsive Disorder
This study is testing if the medication pramipexole can help people with obsessive-compulsive disorder who haven't found relief from other treatments.
-
Evaluating Modafinil's Effect on Cognitive Impairment in Multiple Sclerosis
This study is testing if modafinil can help improve thinking skills in adults with multiple sclerosis and see how brain activity might predict who benefits from the treatment.
-
Evaluating Tryptophan for Treating BPH Symptoms
This study is testing whether Tryptophan can help men with BPH symptoms feel better without the sexual side effects that come with usual treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.